Medicaid is a joint federal-state program that provides medical care to nearly 70 million low-income individuals nationwide. It is a means-tested program that is managed by the states. People served by Medicaid are U.S. citizens or legal permanent residents, including low-income adults, their children, and people with certain disabilities. Medicaid has expanded rapidly since its inception in 1965. This could possibly be linked to the program's financial structure, in which the federal government matches state spending. The incentives are so dysfunctional that states have inflated the cost of health care. • State expenditures on Medicaid have increased from 0.2 percent of tax revenues in 1966 to an estimated 21 percent in 2005. • In 1975, 10 percent of the U.S. population was enrolled in Medicaid, by 2008, 19 percent were enrolled. • In FY 2010, Medicaid surpassed elementary and secondary education as the largest component of total state spending. • ObamaCare will add 18 million people to Medicaid rolls. Even without reform, Medicaid spending may increase by as much as 50 percent in 10 years. This is an unsustainable model. State-by-State Insurance Information is available at this site.

Alabama's Medicaid Drug Program

from NCPA,

One million Alabamans are enrolled in Medicaid, a joint federal-state program that provides medical care to nearly 70 million low-income individuals nationwide. Medicaid consumes over one-third of the General Fund, and costs state and federal taxpayers nearly $6 billion annually — about one-tenth of which participants spend on drugs and drug therapies. Medicaid officials anticipate enrollment will increase as a result of the Patient Protection and Affordable Care Act, says NCPA senior fellow Devon Herrick. In addition, Medicaid spending on drug therapies will rise as the prevalence of costly specialty drugs increases. Thus, slowing the growth of Medicaid drug spending is a fiscal imperative for Alabama's state budget. Drug benefits are an important component of Medicaid. Drug therapy is not only convenient, it is also the most efficient way to treat many health conditions. Moreover, drugs are a relative bargain compared to other medical expenditures. Americans spend twice as much on doctors and about three times as much on hospital care as on drug therapies. However, the cost of drug therapies is rising. Specialty drugs are supplanting the tablets, capsules and elixirs Americans have come to expect from their doctors. And as this occurs, drug spending is expected to grow at an increasing rate. The Menges Group, a consultancy that evaluates state Medicaid programs with an emphasis on special needs populations, identified a few of the ways state Medicaid drug programs waste money.

For example: - Drug prices often differ unnecessarily from one pharmacy to the next. - State Medicaid programs arbitrarily pay much higher dispensing fees than would occur in a competitive market. - State Medicaid fee-for-service drug programs use low-cost, generic drugs less than efficiently-managed programs. - Moreover, the number of redundant and unnecessary prescriptions per Medicaid enrollee is often higher for state-managed fee for service drug programs.

More From NCPA:

365 Days Page
Comment ( 0 )
Leave a Reply